𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage

✍ Scribed by Mahe, Etienne; Akhter, Ariz; Le, Anne; Street, Lelsey; Pournaziri, Payam; Kosari, Farid; Shabani-Rad, Meer-Taher; Stewart, Douglas; Mansoor, Adnan

Book ID
126793060
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
839 KB
Volume
33
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Quantitative monitoring of cyclin D1 exp
Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma
✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati

Expression of the T1 (CD5, p67) surface
Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers
✍ Dr. Domenico Delia; Antonio Bonati; Roberto Giardini; Silvia Villa; Filippo De B πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 742 KB

The TI surface antigen (CD5,p67) expression on blood lymphocytes (PBL) and lymphoid cells from lymph node biopsies (LN) from 31 patients with B-cell chronic lymphocytic leukemia (B-CLL) and 79 with B non-Hodgkin lymphoma (B-NHL), was detected in 25 B-CLL (80 per cent) and in 11 B-NHL (13 per cent) b